| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Chf Strategy &Growth Offi
1 company
Nikolopoulos Nicholas J is an EVP Chf Strategy &Growth Offi at MD. Recent filings cover 0 purchases and 1 sale. Those positions are worth an estimated $1.9M at current prices.
Nikolopoulos Nicholas J's largest disclosed position is in MD as EVP Chf Strategy &Growth Offi, worth about $1.9M. The recent filings there lean toward selling, a net 10,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2020 | MD Pediatrix Medical Group, Inc. | EVP Chf Strategy &Growth Offi | Sell | 10,000 | $19.02 | $190,179.00 | -12.2% |